Well .... ANP has tried that a few times before targeting other indications ....
How has that worked ?
The old adage "this time could be different" ?
Still all about the DMD trial ....
2026 the spot it needs to hit if wants to see the voucher - but really if successful at that point the voucher doesn't mean much .... maybe help fund manufacturing facilities for 2027 and beyond ...
Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2, page-30
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |